These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1316540)

  • 21. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
    Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity.
    Brown TR; Lubahn DB; Wilson EM; French FS; Migeon CJ; Corden JL
    Mol Endocrinol; 1990 Dec; 4(12):1759-72. PubMed ID: 2082179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
    Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function.
    Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    Steroids; 2013 Dec; 78(12-13):1288-92. PubMed ID: 24055831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testicular feminization associated with a thermolabile androgen receptor in culutred human fibroblasts.
    Griffin JE
    J Clin Invest; 1979 Dec; 64(6):1624-31. PubMed ID: 500829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
    Govindan MV
    Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J; Mongan NP; Harland S; Hughes IA
    Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular defects of the androgen receptor.
    McPhaul MJ
    J Steroid Biochem Mol Biol; 1999; 69(1-6):315-22. PubMed ID: 10419008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point mutations detected in the androgen receptor gene of three men with partial androgen insensitivity syndrome.
    Saunders PT; Padayachi T; Tincello DG; Shalet SM; Wu FC
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):214-20. PubMed ID: 1424203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single amino acid substitution (Met786----Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome.
    Nakao R; Haji M; Yanase T; Ogo A; Takayanagi R; Katsube T; Fukumaki Y; Nawata H
    J Clin Endocrinol Metab; 1992 May; 74(5):1152-7. PubMed ID: 1569163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics.
    Ris-Stalpers C; Trifiro MA; Kuiper GG; Jenster G; Romalo G; Sai T; van Rooij HC; Kaufman M; Rosenfield RL; Liao S
    Mol Endocrinol; 1991 Oct; 5(10):1562-9. PubMed ID: 1775137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor.
    Imasaki K; Hasegawa T; Okabe T; Sakai Y; Haji M; Takayanagi R; Nawata H
    Eur J Endocrinol; 1994 Jun; 130(6):569-74. PubMed ID: 8205256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.
    Rennie PS; Bruchovsky N; Leco KJ; Sheppard PC; McQueen SA; Cheng H; Snoek R; Hamel A; Bock ME; MacDonald BS
    Mol Endocrinol; 1993 Jan; 7(1):23-36. PubMed ID: 8446105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor defects: historical, clinical, and molecular perspectives.
    Quigley CA; De Bellis A; Marschke KB; el-Awady MK; Wilson EM; French FS
    Endocr Rev; 1995 Jun; 16(3):271-321. PubMed ID: 7671849
    [No Abstract]   [Full Text] [Related]  

  • 38. G708E mutation in the androgen receptor results in complete loss of androgen function.
    Rajender S; Pooja S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    J Androl; 2011; 32(2):193-8. PubMed ID: 20671138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
    Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of androgen insensitivity syndromes: molecular and structural approaches of natural and engineered androgen receptor mutations at amino acid 743.
    Poujol N; Lumbroso S; Térouanne B; Lobaccaro JM; Bourguet W; Sultan C
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5793-800. PubMed ID: 12466388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.